Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthma

Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthma

Abstract Background Omalizumab is approved for treating severe allergic asthma from age 6, but the definition of severe asthma including a systematic assessment to rule out difficult-to-treat asthma has changed since the drug was approved in 2003. Methods We conducted a systematic review and meta-an...

Full description

Bibliographic Details
Main Authors: Daniel P. Henriksen, Uffe Bodtger, Kirsten Sidenius, Niels Maltbaek, Lars Pedersen, Hanne Madsen, Ehm A. Andersson, Ole Norgaard, Louise K. Madsen, Bo L. Chawes
Format: Article
Language:English
Published: BMC 2020-06-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Severe asthma
Anti-IgE
Omalizumab
Systematic review
Online Access:http://link.springer.com/article/10.1186/s13223-020-00442-0

Similar Items

Similar Items